RU2687249C2 - Способ лечения заболевания с помощью аурикулярной анестезии черепных нервов - Google Patents

Способ лечения заболевания с помощью аурикулярной анестезии черепных нервов Download PDF

Info

Publication number
RU2687249C2
RU2687249C2 RU2015148757A RU2015148757A RU2687249C2 RU 2687249 C2 RU2687249 C2 RU 2687249C2 RU 2015148757 A RU2015148757 A RU 2015148757A RU 2015148757 A RU2015148757 A RU 2015148757A RU 2687249 C2 RU2687249 C2 RU 2687249C2
Authority
RU
Russia
Prior art keywords
nerve
pharmaceutical composition
pain
present
per
Prior art date
Application number
RU2015148757A
Other languages
English (en)
Russian (ru)
Other versions
RU2015148757A (ru
Inventor
Томас М. КРЮС
Original Assignee
Томас М. КРЮС
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Томас М. КРЮС filed Critical Томас М. КРЮС
Publication of RU2015148757A publication Critical patent/RU2015148757A/ru
Application granted granted Critical
Publication of RU2687249C2 publication Critical patent/RU2687249C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
RU2015148757A 2013-05-03 2014-05-05 Способ лечения заболевания с помощью аурикулярной анестезии черепных нервов RU2687249C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361819023P 2013-05-03 2013-05-03
US61/819,023 2013-05-03
PCT/US2014/036855 WO2014179814A1 (en) 2013-05-03 2014-05-05 Method of treating disease by auricular anesthesia of cranial nerves

Publications (2)

Publication Number Publication Date
RU2015148757A RU2015148757A (ru) 2017-06-08
RU2687249C2 true RU2687249C2 (ru) 2019-05-08

Family

ID=51844020

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2015148757A RU2687249C2 (ru) 2013-05-03 2014-05-05 Способ лечения заболевания с помощью аурикулярной анестезии черепных нервов
RU2018118068A RU2701548C1 (ru) 2013-05-03 2016-11-02 Способ лечения болезни аурикулярной анестезией черепных нервов

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2018118068A RU2701548C1 (ru) 2013-05-03 2016-11-02 Способ лечения болезни аурикулярной анестезией черепных нервов

Country Status (17)

Country Link
US (5) US20140357686A1 (enExample)
EP (2) EP2991620B1 (enExample)
JP (3) JP6433985B2 (enExample)
KR (2) KR102086709B1 (enExample)
CN (2) CN105163718B (enExample)
AU (2) AU2014262148B2 (enExample)
CA (2) CA2910422C (enExample)
DK (1) DK2991620T3 (enExample)
ES (1) ES2823624T3 (enExample)
HK (1) HK1212230A1 (enExample)
IL (2) IL242339B (enExample)
MX (2) MX381106B (enExample)
MY (2) MY180310A (enExample)
RU (2) RU2687249C2 (enExample)
SG (1) SG11201508509XA (enExample)
WO (2) WO2014179814A1 (enExample)
ZA (2) ZA201508782B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2910422C (en) * 2013-05-03 2022-09-27 Thomas M. Crews Method of treating disease by auricular anesthesia of cranialnerves
EP3263103A4 (en) * 2015-02-26 2018-03-14 Limited Liability Company "konsortsium-pik" Pharmaceutical composition for treatment of inflammatory ear diseases, method for producing same and method for treatment using said composition
EP3509585B1 (en) 2016-09-07 2023-11-01 Glia, LLC Treatment of symptoms related to neurodegenerative disorders through pharmacological dermal activation of cranial nerves
US20220105052A1 (en) * 2016-12-26 2022-04-07 Cellix Bio Private Limited Compositions and methods for the treatment of chronic pain
CN107789621A (zh) * 2017-12-15 2018-03-13 阜阳市平衡医疗保健器械有限公司 一种治疗头痛的药物及其配制方法
US11607275B2 (en) * 2019-05-20 2023-03-21 Medtronic Ireland Manufacturing Unlimited Company Selection of hypertensive patients for treatment with renal denervation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2104056C1 (ru) * 1995-07-10 1998-02-10 Александр Александрович Ланцов Способ лечения периферических поражений лицевого нерва
US6093417A (en) * 1999-01-11 2000-07-25 Advanced Medical Instruments Composition to treat ear disorders
US6159145A (en) * 1996-08-02 2000-12-12 Satoh; Mieko Appetite adjusting tool
US20110208161A1 (en) * 2009-08-13 2011-08-25 Yehuda Ivri Intracochlear drug delivery to the central nervous system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19524691A1 (de) * 1995-07-06 1997-01-09 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen
AU5170400A (en) * 1999-05-27 2000-12-18 George F. El Khoury Topical application of muscarinic and opioid agents for treatment of tinnitus
DE10322497A1 (de) * 2003-05-19 2004-12-09 Liedtke, Rainer K., Dr. Topisch pharmakologische Vorbeugung und Therapie der Hyperakusis
US8940321B2 (en) * 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
US8755892B2 (en) * 2007-05-16 2014-06-17 Cardiac Pacemakers, Inc. Systems for stimulating neural targets
WO2011028915A2 (en) * 2009-09-03 2011-03-10 University Of Chicago Platelet aggregation inhibitors
CA2848730A1 (en) * 2011-09-15 2013-03-21 Yoseph Yaacobi Systems and methods for treating ear disorders
CA2910422C (en) * 2013-05-03 2022-09-27 Thomas M. Crews Method of treating disease by auricular anesthesia of cranialnerves

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2104056C1 (ru) * 1995-07-10 1998-02-10 Александр Александрович Ланцов Способ лечения периферических поражений лицевого нерва
US6159145A (en) * 1996-08-02 2000-12-12 Satoh; Mieko Appetite adjusting tool
US6093417A (en) * 1999-01-11 2000-07-25 Advanced Medical Instruments Composition to treat ear disorders
US20110208161A1 (en) * 2009-08-13 2011-08-25 Yehuda Ivri Intracochlear drug delivery to the central nervous system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ЛОБЗИН С.В. "Пункции и блокады в неврологии". Блокада ветвей тройничного нерва. 2007, найдено 23.04.2018 из Интернет: bib.social/nevrologiya_1068/blokada-vetvey-troynichnogo-107245,html.. *

Also Published As

Publication number Publication date
ES2823624T3 (es) 2021-05-07
JP7512317B2 (ja) 2024-07-08
AU2014262148B2 (en) 2018-11-22
JP2016522819A (ja) 2016-08-04
IL242339B (en) 2020-05-31
ZA201508782B (en) 2017-08-30
BR112018008893A8 (pt) 2019-02-26
MX2018005625A (es) 2018-12-06
AU2014262148A1 (en) 2015-11-05
RU2701548C1 (ru) 2019-09-30
WO2014179814A1 (en) 2014-11-06
MX2015015194A (es) 2016-02-11
BR112018008893A2 (pt) 2018-11-06
HK1212230A1 (en) 2016-06-10
EP3370716A4 (en) 2019-04-17
NZ713746A (en) 2021-01-29
JP6433985B2 (ja) 2018-12-05
JP2022065015A (ja) 2022-04-26
NZ742076A (en) 2024-12-20
AU2016349784B2 (en) 2019-06-06
CA3004160A1 (en) 2017-05-11
US20160051516A1 (en) 2016-02-25
ZA201803483B (en) 2019-08-28
US20220387307A1 (en) 2022-12-08
CA3004160C (en) 2023-03-14
MX381106B (es) 2025-03-04
EP2991620A4 (en) 2017-01-11
MX390998B (es) 2025-03-21
KR20160003012A (ko) 2016-01-08
EP3370716A1 (en) 2018-09-12
AU2016349784A1 (en) 2018-05-17
MY180310A (en) 2020-11-28
CN108430470A (zh) 2018-08-21
US20260083666A1 (en) 2026-03-26
US20140357686A1 (en) 2014-12-04
US20180360745A1 (en) 2018-12-20
JP2018536709A (ja) 2018-12-13
IL259019A (en) 2018-06-28
US11123284B2 (en) 2021-09-21
WO2017079270A1 (en) 2017-05-11
DK2991620T3 (da) 2020-10-12
CA2910422C (en) 2022-09-27
KR20180088408A (ko) 2018-08-03
EP2991620A1 (en) 2016-03-09
MY196979A (en) 2023-05-16
CN105163718B (zh) 2020-03-17
CN105163718A (zh) 2015-12-16
IL259019B (en) 2021-06-30
KR102086709B1 (ko) 2020-03-09
KR102796310B1 (ko) 2025-04-16
RU2015148757A (ru) 2017-06-08
CA2910422A1 (en) 2014-11-06
US9968589B2 (en) 2018-05-15
EP2991620B1 (en) 2020-07-08
SG11201508509XA (en) 2015-11-27

Similar Documents

Publication Publication Date Title
US20260083666A1 (en) Method of treating disease
Loft et al. Hiccups: a case presentation and etiologic review
Jankovic Regional nerve blocks and infiltration therapy: Textbook and color atlas
RU2480195C1 (ru) Способ лечения заболеваний внутреннего уха
Begani et al. Anesthesia in day care surgery
NZ713746B2 (en) Method of treating disease by auricular anesthesia of cranial nerves
Spiller TUMOR OF THE GASSERIAN GANGLION. 1
Angelova et al. Innovative approaches to the treatment of sleep apnoea
BR112018008893B1 (pt) Composição farmacêutica óptica
Dornhoffer et al. Pathophysiology of the Eustachian tube: The Patulous Eustachian tube
CHRONICA et al. In approaching the subject of the modification of a radical operation, we should keep constantly in mind that the raison d'etre of the operation is to leave as serviceable an ear with as little hardship to the patient as possible. Sterotyped operations about the ear are even more objectionable than
RU2502528C1 (ru) Способ воздействия на организм
Walters Symptoms of Disease
Russel The treatment of diseases of the cranial nerves and organic lesions of the spinal cord.